HopeStage
Back to all studies
RecruitingNCT06795451

Spinal stimulation and body-signal processing in major depression

About this titleRead the official source — NCT06795451
Device studyAges 18–60United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
67
Sponsor
University of Cincinnati
Sponsor type
University
Study type
Device
Intervention type
Device
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT06795451
Official title
Show the full official title

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

Recruitment & locations

Currently recruiting

Mason

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Cincinnati, a university.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies